MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
RESEARCH ARTICLE
Received: 13 Aug 2024
Revised: 27 Aug 2024
Accepted: 01 Sep 2024
*Corresponding author's e-mail: drgeethaprincy@gmail.com
Synthesis and characterization of insulin-loaded nanoparticles
fortified milk
P.Geetha*1 and M.Esther Magdalene Sharon2
Assistant Professor, 1Department of Food Processing Technology,
Assistant Professor, 2Dairy Chemistry,
College of Food and Dairy Technology,
Tamil Nadu Veterinary and Animal Sciences University, Chennai-600052,
ABSTRACT
Type 1 diabetes caused by the destruction of the pancreatic cells, leads
to reduced or no production of insulin, the hormone responsible for lowering
blood glucose levels. Insulin is a protein administered subcutaneously to
humans for treating, type I diabetes mellitus to control glucose homeostasis
when pancreatic β-cells production is not sufficient to ensure daily needs of
this hormone. The desire for a more convenient and socially compatible route
of insulin administration other than subcutaneous injection has originated
several approaches to attempt its oral delivery. The aim of this project is
to research and obtain a therapeutic food product containing an oral
insulin delivery system. The method used to synthesize the insulin loaded
nanoparticles is a two step Ionic pre-gelation method for the preparation
of alginate/chitosan nanoparticles. The sizes of the alginate-chitosan
nanoparticles were estimated by Scanning Electron Microcopy to range from
326-850nm. The characterization of the synthesized nanoparticles was
done using Scanning electron microsopy (SEM), Fourier Transform Infrared
spectroscopy (FTIR) and X-Ray Diffraction (XRD) studies. The interaction
between the Alginate and Chitosan was confirmed by the FTIR studies. From
the results of the XRD studies, it was observed that there was a decline in
the crystal structure of the Chitosan after the formation of the nanoparticles.
These Nanoparticles were homogenized with Ultra High Temperature (UHT)
sterilized milk containing 4.5% fat. The standard milk (control) and the milk
containing nanoparticles (product) was subjected to sensory analysis for the
color, aroma and consistency. From the sensory analysis of color, aroma and
consistency, it was found that there was no significant difference between
the control and the product.
Keywords: Alginate, Chitosan, Insulin, Therapeutic Milk, Oral Delivery System
INTRODUCTION
Diabetes is referred to a collection of disorders
defined by elevated blood glucose levels. The condition
arises from an insufficiency in insulin synthesis or
activity, or both, due to various factors, leading to
metabolic abnormalities of proteins and lipids. The
prolonged consequences of hypoglycemia include
harm to tissues and organs. Individuals with type 1
diabetes are incapable of producing sufficient insulin.
This category accounts for around 5%–10% of all
diabetes cases. This type involves the cellular death
of beta cells in the pancreas. In type 1 diabetes, the
pancreas fails to secrete insulin. Insulin is delivered
via subcutaneous injection to manage individuals with
type 1 diabetes (Mobasseri et al., 2020).
In addition to the psychological barriers for the use
of insulin in injectable form, its use is accompanied
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
by different complications such as hypoglycemia,
lipoatrophy at the injection site and all other risks
associated with injections. These complications make
the search into alternative routes for insulin delivery
is necessity. The other most studied routes are oral,
nasal, buccal and pulmonary. Buccal route is based
on the micellar solublisation. Nasal route was fully
investigated but no commercial exploitation is taking
place. Pulmonary route was commercially exploited
but unfortunately was withdrawn from the market.
Nevertheless, oral route is the most desired and has
been investigated thoroughly (Elsayed et al., 2011).
Oral delivery system is the preferred route for
administration because it is non-invasive, avoids
injections and decreases the risk of infections. It is also
physiologically desirable since the exogenous protein
imitates the physiological pathway undergoing first
hepatic bypass. The intestinal absorption of proteins
has been reported in a combination of mechanisms
described to explain how the protein cross the intestinal
mucosa (Sarmento et al., 2007). Peptide and protein
drugs are intrinsically poorly absorbable through the
intestinal membrane owing to high molecular weight
and hydrophilicity. Moreover, they are highly susceptible
for enzymatic degradation in the gastrointestinal
(GI) tract after oral administration. Entrapment of
peptides drugs in micro- and nanoparticulate carriers
protects them against the harsh environment of the
GI tract until they are absorbed in released or intact
particular form. In addition, formulations of the carrier
system using mucoadhesive polymers prolongs the
direct contact of the particles to the mucosal surface,
achieves higher local drug concentration in the mucus
layer, and minimizes drug dilution and degradation by
the luminal content (Li et al., 2008).
Nanoparticles
consisting
of
synthetic
biodegradable polymers, natural biopolymers, lipids
and polysaccharides have been developed and tested
over the past decades. Recently, the idea of using
nanoparticles made from natural biodegradable
polymers to deliver drugs has provoked great
interests. Among them, alginate and chitosan are
very promising and have been widely exploited in
pharmaceutical industry for controlling drug release
(Makhlof et al., 2011). Sodium Alginate has a unique
property of cross linking in the presence of multivalent
cations such as calcium ions in aqueous media.
Alginate forms a reticulated structure in contact with
calcium ions and this network can entrap proteins.
Chitosan is a linear copolymer polysaccharide and it
is produced commercially by deacetylation of chitin,
which is the structural element in the exoskeleton of
the crustaceans. The strong electrostatic interaction of
the amino groups of the chitosan with the carboxylic
groups of the alginate leads to the formation of
the complex chitosan/alginate that becomes the
polyelectrolyte complex between chitosan and alginate
has been widely used in order to obtain microcapsules
for cell encapsulation and devices for the controlled
release of drugs or other substances (Finotelli et al.,
2010).
There is a growing awareness nowadays of
the health benefits of a category of bioactive food
constituents known as nutraceuticals. This has
created society demand for products (functional
foods) and preparations rich in these constituents
to improve public health. It is well documented that
their consumption produces physiological benefits or
reduce the long-term risk of developing degenerative
diseases. On the other hand, the added bioactive
constituents may have some undesirable effects on
the taste and odour of the food matrix used as many of
these constituents have undesirable taste and odour.
Therefore, the objectives of food manufacturers and
nutritionists have been to maximize the availability of
administered nutraceuticals without compromising
consumer acceptability (Salam et al., 2012). This
study aims to develop functional dairy food (milk) with
oral insulin delivery system to overcome the limitations
of the painful subcutaneous injections of insulin
administration and produce a more patient friendly
method of insulin administration. It involves the
synthesis, characterization and mixing of the insulin
loaded nanoparticles into milk and observation of the
settling and dispersion in it.
MATERIAL AND METHODS
Materials
Sodium alginate, chitosan and calcium chloride were
purchased from Himedia Laboratories. Recombinant
human isophane insulin was purchased under the
brand name of Humulin N®from Biocon Laboratory,
India. Milk used in this study was purchased from the
local market. UHT sterilized standard milk (4.5% fat)
which was marketed by Amul Dairy under the Brand
name of Amul Gold was used in this study. Deioinzed
water (Milli-Q®) was used throughout the process as a
medium.
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Preparation of Nanoparticles
Insulin loaded Alginate-Chitosan Nanoparticles
were produced by dilute alginate solutions containing
insulin by inducing an ionotropic pre-gel with calcium
counter ions followed by polyelectrolyte complex
coating with Chitosan as described by Sarmento et al,
2007). with isophane insulin as source of insulin.
Nanoparticle Characterization
The prepared nanoparticles were characterized
using scanning electron microscopy, Fourier transform
infrared spectroscopy and x-ray diffraction studies.
The morphology such as the shape, size and the
occurrence of aggregation of particles were studied by
scanning electron microscopy. The interaction between
the various components of the nanoparticulate
systems were studied using Fouriertransform infrared
spectroscopy. The crystalline nature of the components
of the nanoparticles namely, the alginate and the
chitosan were studied using x-ray diffraction studies
before and after the formation of the nanoparticles.
Scanning Electron Microscopy
Scanning electron microscopy was done using a low
vacuum FEI QuantaFEGSEM (5kV) at 80 Torr. Alginate
chitosan nanoparticles were synthesized with three
different concentrations of chitosan. This synthesis
was carried out and the influence of the chitosan
concentration on the size of the nanoparticles formed
was studied using scanning electron microscopy. The
lyophilized nanoparticles powders were mounted on
a stub using a carbon tape and then examined for
the shape, size and the aggregation nature of the
nanoparticles.
Fourier Transform Infrared Spectroscopy
FTIR spectra were measured using a Bruker-α
spectrometer. The samples were gently mixed with
micronized KBr powder and compressed into discs
at a force of 10 kN for 1 minute using a manual
tablet presser. The interferogram was collected in
absorption from 400 cm-1 and 4000cm-1 region at
room temperature.
X-Ray Diffraction
X-Ray diffraction of the lyophilized powder samples
was done using PANalyticalXpert Pro XRD in powder
mode. The scanning was done at the rate of 0.05°/
step and 2 sec/step with CuKα as the source of x-ray
with a wavelength of 0.154 nm. The powdered samples
of chitosan, alginate, alginate/chitosan nanoparticles
and insulin loaded alginate/chitosan nanoparticles
were analysed for the crystalline nature.
Association Efficiency (AE)
The association efficiency of the insulin to the
nanoparticles was analysed to find out the amount
of insulin bound to the nanoparticles. The insulin
determinations were done in triplicates. It was
calculated using the following formula:
In-Vitro Insulin Release Studies
The insulin release profile from nanoparticles
in simulated gastric and intestinal pH was carried
out to study the amount of insulin released from
the nanoparticles in to the medium simulating the
stomach and intestinal conditions. The nanoparticles
were placed into test tubes containing 20 mL of HCl
buffer pH 1.5 or PBS buffer pH 7.4. At appropriate
intervals of 30 minutes, aliquots of 500 µL were
taken and replaced by fresh buffer. Aliquots were
centrifuged at 5000g for 15 minutes. The amount of
insulin released from the nanoparticles was evaluated
by HPLC.
Incorporation of nanoparticles into milk
The lyophilized nanoparticles in the form of
powders were added to UHT pasteurized milk. The
total yield of powders from a single batch of prepared
nanoparticles was added to 100 mLmLof UHT
pasteurized milk using a blender. The milk containing
the insulin loaded nanoparticles was kept at 4°C. The
addition of the nanoparticles was done under sterile
conditions to prevent the spoilage of the product.
Sensory analysis
The standard milk and the milk containing insulin
loaded nanoparticles were evaluated for acceptability
by a panel of judges for aroma, color and appearance,
consistency according to 9-point hedonic scale
wherein a score of 1 represented dislike extremely
and score of 9 represented like extremely.
RESULTS AND DISCUSSION
Synthesis and characterization of Insulin loaded
nanoparticles by Spontaneous Emulsification
Solvent Diffusion Method
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Chitosan solutions at concentrations of 0.05%,
0.07%, and 0.09% were prepared for analysis, with
the dimensions and characteristics of the resulting
nanoparticles detailed in Table 1. Each experiment
was conducted in triplicate.
Scanning electron micrographs revealed that
the synthesis process using the lowest chitosan
concentration
(0.05%)
produced
cylindrical
nanofibers, as shown in Figure 1. Table 2 presents the
variance analysis for nanoparticle sizes at chitosan
concentrations of 0.07% and 0.09%, indicating that
the size reduction between these concentrations
was
statistically
insignificant.
The
scanning
electron micrographs of the nanoparticles produced
from the three chitosan concentrations—0.05%,
0.07%, and 0.09%—are shown in Figures 1, 2, and 3,
respectively.
The size of the nanoparticles was measured
to be 68.4±2.800 nm and 66.7±1.201 nm when
synthesizing nanoparticles with starting chitosan
concentrations of 0.07% and 0.09%, respectively.
Particles of a size smaller than 100 nm shown a 2.5-
fold increase in uptake compared to microparticles
measuring 1µm (Panyam and Labhasetwar, 2003).
Preliminary attention was given to polyelectrolyte
interactions and insulin trapping in order to
investigate the linkages between components of the
nanoparticulate systems. The interaction between
the carboxyl (-COO-) group of the anionic polymer
and the amino group (-NH3+) of chitosan is a known
phenomenon. This interaction leads to the formation
of an ionic complex between the two molecules, as
described by Sarmento et al, 2006).
Fourier Transform Infrared (FTIR) spectroscopy
The synthesis of insulin-loaded nanoparticles
was carried out, and the interactions between the
nanoparticle constituents, specifically chitosan and
alginate, were analyzed using Fourier Transform
Infrared (FTIR) spectroscopy. Figure 4 shows the FTIR
spectrum of pure chitosan, which was examined to
identify the highest values within the ranges of 3000–
3120 cm⁻¹, 1480–1530 cm⁻¹, and 1590–1620 cm⁻¹.
These peaks correspond to the presence of amino
groups (-NH₃⁺) in the spectrum. The observed peaks in
Figure 4 confirm the presence of amino groups (-NH₃⁺)
in pure chitosan at wavenumbers of 1501.72 cm⁻¹,
1654.73 cm⁻¹, 3045.94 cm⁻¹, 3079.94 cm⁻¹, and
3147.95 cm⁻¹.
The highest point within the range of 1710 cm-1
– 1740 cm-1 indicates the existence of saturated
carboxylic acids. Figure 5 displays a prominent signal
at 1738.31 cm-1, indicating the existence of the
carboxylic group in the alginate solution employed for
nanoparticle production.
Table 1.The initial concentration of chitosan, size and nature of the nanoparticles
S.No.
Chitosan Concentration%
( w/v)
Size (in nm)
Nature
1
0.05
--
Nanofibres like structures
2
0.07
68.4±2.800
Agglomerated
3
0.09
66.7±1.201
Agglomerated
Table 2 Peak Values of FTIR spectrum of Alginate, Chitosan, and Nanoparticles formed with initial
chitosan concentrations of 0.05%, 0.07%, and 0.09%.
Samples
Alginate (COO-) &
Chitosan (NH3
+)
Initial Concentration of Chitosan
Functional groups
0.05%
0.07%
0.09%
COO--
1738.31
1738.49
1732.83
1742.75
NH3
+
1501.72
1517.46
1525.96
1514.23
1654.73
1640.73
1606.73
1646.40
3045.94
3284.30
3355.14
2920.16
3079.94
3315.47
3386.31
2952.75
3147.95
3348.05
3416.06
3455.74
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Fig 2. Scanning Electron Micrographs of nanoparticles with initial chitosan concentration of 0.07%
The size of the nanoparticles was measured to be 68.4±2.800 nm and 66.7±1.201 nm when
synthesizing nanoparticles with starting chitosan concentrations of 0.07% and 0.09%, respectively.
Particles of a size smaller than 100 nm shown a 2.5-fold increase in uptake compared to microparticles
measuring 1µm (Panyam and Labhasetwar, 2003).
Fig 3. Scanning Electron Micrographs of Nanoparticles synthesized with initial chitosan concentration of
0.09%
Preliminary attention was given to polyelectrolyte interactions and insulin trapping in order to investigate
the linkages between components of the nanoparticulate systems. The interaction between the carboxyl (-
COO-) group of the anionic polymer and the amino group (-NH3+) of chitosan is a known phenomenon. This
interaction leads to the formation of an ionic complex between the two molecules, as described by
Sarmento et al, 2006).
Fourier Transform Infrared (FTIR) spectroscopy
The synthesis of insulin loaded nanoparticles was carried out and the interactions between the
Fig 3. Scanning Electron Micrographs of Nanoparticles synthesized with initial chitosan
concentration of 0.09%
Volume 111 | Issue 7-9 |
Scanning electron micrographs revealed that the synthesis process using the lowest chitosan
concentration (0.05%) produced cylindrical nanofibers, as shown in Figure 1. Table 2 presents the variance
analysis for nanoparticle sizes at chitosan concentrations of 0.07% and 0.09%, indicating that the size
reduction between these concentrations was statistically insignificant. The scanning electron micrographs
of the nanoparticles produced from the three chitosan concentrations—0.05%, 0.07%, and 0.09%—are
shown in Figures 1, 2, and 3, respectively.
Fig 1.Scanning Electron Micrographs of nanofibre-like structures formed with initial Chitosan Concentration
of 0.05%
Fig 2. Scanning Electron Micrographs of nanoparticles with initial chitosan concentration of 0.07%
Volume 111 | Issue 7-9 |
(
) p
y
,
g
p
analysis for nanoparticle sizes at chitosan concentrations of 0.07% and 0.09%, indicating that the size
reduction between these concentrations was statistically insignificant. The scanning electron micrographs
of the nanoparticles produced from the three chitosan concentrations—0.05%, 0.07%, and 0.09%—are
shown in Figures 1, 2, and 3, respectively.
Fig 1.Scanning Electron Micrographs of nanofibre-like structures formed with initial Chitosan Concentration
of 0.05%
An analysis was conducted on nanoparticles
synthesized
using
chitosan
concentrations
of
0.05%, 0.07%, and 0.09% to examine the presence
of amino and carboxyl groups in their respective
FTIR spectra. Figure 6 displays the FTIR spectra of
alginate, chitosan, and nanoparticles prepared with
chitosan concentrations of 0.05%, 0.07%, and 0.09%,
respectively. The peak values for chitosan, alginate,
and the nanoparticles synthesized with initial chitosan
concentrations of 0.05%, 0.07%, and 0.09% are
presented in Table 2. Each spectrum was individually
analyzed to identify any shifts in the peak values of
the amino and carboxyl groups, which would suggest
interactions between chitosan and alginate in the
nanoparticulate systems.
Fig 1.Scanning Electron Micrographs of nanofibre-like structures formed with initial Chitosan
Concentration of 0.05%
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Fig 4. FTIR spectrum of Chitosan
The highest point within the range of 1710 cm-1 – 1740 cm-1 indicates the existence of saturated
carboxylic acids. Figure 5 displays a prominent signal at 1738.31 cm-1, indicating the existence of the
carboxylic group in the alginate solution employed for nanoparticle production.
Figure 5 FTIR spectrum of alginate
An analysis was conducted on nanoparticles synthesized using chitosan concentrations of 0.05%, 0.07%,
and 0.09% to examine the presence of amino and carboxyl groups in their respective FTIR spectra. Figure
6 displays the FTIR spectra of alginate, chitosan, and nanoparticles prepared with chitosan concentrations
of 0.05%, 0.07%, and 0.09%, respectively. The peak values for chitosan, alginate, and the nanoparticles
synthesized with initial chitosan concentrations of 0.05%, 0.07%, and 0.09% are presented in Table 2.
Each spectrum was individually analyzed to identify any shifts in the peak values of the amino and carboxyl
groups, which would suggest interactions between chitosan and alginate in the nanoparticulate systems.
The analysis revealed a slight shift in the peak values of the carboxyl group. Specifically, the peak
shifted from 1738.31 cm⁻¹ in alginate to 1738.49 cm⁻¹ in nanoparticles with an initial chitosan
concentration of 0.05%. Additionally, there was a shift in the peak values of the amino groups, moving from
1501.72 cm⁻¹.
The wavenumber range for chitosan was observed between 1654.73 cm⁻¹ and 3147.95 cm⁻¹,
while for nanoparticles synthesized with a chitosan concentration of 0.05%, the range extended from
1517.46 cm⁻¹ to 3348.05 cm⁻¹.
Volume 111 | Issue 7-9 |
Infrared (FTIR) spectroscopy. Figure 4 shows the FTIR spectrum of pure chitosan, which was examined to
identify the highest values within the ranges of 3000–3120 cm⁻¹, 1480–1530 cm⁻¹, and 1590–1620
cm⁻¹. These peaks correspond to the presence of amino groups (-NH₃⁺) in the spectrum. The observed
peaks in Figure 4 confirm the presence of amino groups (-NH₃⁺) in pure chitosan at wavenumbers of
1501.72 cm⁻¹, 1654.73 cm⁻¹, 3045.94 cm⁻¹, 3079.94 cm⁻¹, and 3147.95 cm⁻¹.
Fig. 5 FTIR spectrum of alginate
The analysis revealed a slight shift in the peak
values of the carboxyl group. Specifically, the peak
shifted from 1738.31 cm⁻¹ in alginate to 1738.49 cm⁻¹
in nanoparticles with an initial chitosan concentration
of 0.05%. Additionally, there was a shift in the peak
values of the amino groups, moving from 1501.72
cm⁻¹.
The wavenumber range for chitosan was observed
between 1654.73 cm⁻¹ and 3147.95 cm⁻¹, while
for nanoparticles synthesized with a chitosan
concentration of 0.05%, the range extended from
1517.46 cm⁻¹ to 3348.05 cm⁻¹.
The spectra indicate a shift in the peak values
of the carboxyl group, moving from 1738.31 cm⁻¹ in
alginate to 1732.38 cm⁻¹ in nanoparticles with an
initial chitosan concentration of 0.05%. Similarly,
shifts are observed in the peak values of the amino
groups, which change from 1501.72 cm⁻¹, 1654.73
cm⁻¹, 3045.94 cm⁻¹, 3079.94 cm⁻¹, and 3147.95
cm⁻¹ in chitosan to 1525.96 cm⁻¹, 1606.73 cm⁻¹,
3355.14 cm⁻¹, 3386.47 cm⁻¹, and 3416.06 cm⁻¹ in
nanoparticles formed with a chitosan concentration of
0.07%.
For nanoparticles prepared with an initial chitosan
concentration of 0.09%, the carboxyl group peak
shifted from 1738.31 cm⁻¹ in alginate to 1742.75
cm⁻¹ in the nanoparticles. The amino group peaks
also displayed changes, moving from 1501.72 cm⁻¹,
1654.73 cm⁻¹, 3045.94 cm⁻¹, 3079.94 cm⁻¹, and
3147.95 cm⁻¹ in chitosan to 1514.23 cm⁻¹, 1646.40
cm⁻¹, 2920.16 cm⁻¹, 2952.75 cm⁻¹, and 3455.74
cm⁻¹ in the nanoparticles, respectively.
The results of the study indicate that the shifts in the
peaks representing the amino group and the carboxyl
groups in the FTIR spectrum of the nanoparticles
provide evidence of the interaction between the
carboxyl (-COO-) group of the anionic polymer and the
amino group (-NH3+) of Chitosan. This interaction
leads to the formation of an ionic complex between
the two compounds in the nanoparticulate system.
X-ray diffraction (XRD) studies
The nanoparticles containing Humulin N, along
with
the
nanoparticulate
system
components,
chitosan and alginate, were analyzed using X-ray
diffraction (XRD) to assess any
Fig 4. FTIR spectrum of Chitosan
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Volume 111 | Issue 7-9 |
carboxylic group in the alginate solution employed for nanoparticle production.
Figure 5 FTIR spectrum of alginate
An analysis was conducted on nanoparticles synthesized using chitosan concentrations of 0.05%, 0.07%,
and 0.09% to examine the presence of amino and carboxyl groups in their respective FTIR spectra. Figure
6 displays the FTIR spectra of alginate, chitosan, and nanoparticles prepared with chitosan concentrations
of 0.05%, 0.07%, and 0.09%, respectively. The peak values for chitosan, alginate, and the nanoparticles
synthesized with initial chitosan concentrations of 0.05%, 0.07%, and 0.09% are presented in Table 2.
Each spectrum was individually analyzed to identify any shifts in the peak values of the amino and carboxyl
groups, which would suggest interactions between chitosan and alginate in the nanoparticulate systems.
The analysis revealed a slight shift in the peak values of the carboxyl group. Specifically, the peak
shifted from 1738.31 cm⁻¹ in alginate to 1738.49 cm⁻¹ in nanoparticles with an initial chitosan
concentration of 0.05%. Additionally, there was a shift in the peak values of the amino groups, moving from
1501.72 cm⁻¹.
The wavenumber range for chitosan was observed between 1654.73 cm⁻¹ and 3147.95 cm⁻¹,
while for nanoparticles synthesized with a chitosan concentration of 0.05%, the range extended from
1517.46 cm⁻¹ to 3348.05 cm⁻¹.
Fig 6. FTIR spectrum of Chitosan (blue), Alginate (red), and Nanoparticles with initial chitosan
concentration of 0.05% (green), 0.07% (orange), and 0.09% (violet)
The spectra indicate a shift in the peak values of the carboxyl group, moving from 1738.31 cm⁻¹ in alginate
to 1732.38 cm⁻¹ in nanoparticles with an initial chitosan concentration of 0.05%. Similarly, shifts are
observed in the peak values of the amino groups, which change from 1501.72 cm⁻¹, 1654.73 cm⁻¹,
3045.94 cm⁻¹, 3079.94 cm⁻¹, and 3147.95 cm⁻¹ in chitosan to 1525.96 cm⁻¹, 1606.73 cm⁻¹, 3355.14
cm⁻¹, 3386.47 cm⁻¹, and 3416.06 cm⁻¹ in nanoparticles formed with a chitosan concentration of 0.07%.
For nanoparticles prepared with an initial chitosan concentration of 0.09%, the carboxyl group peak shifted
from 1738.31 cm⁻¹ in alginate to 1742.75 cm⁻¹ in the nanoparticles. The amino group peaks also
displayed changes, moving from 1501.72 cm⁻¹, 1654.73 cm⁻¹, 3045.94 cm⁻¹, 3079.94 cm⁻¹, and
3147.95 cm⁻¹ in chitosan to 1514.23 cm⁻¹, 1646.40 cm⁻¹, 2920.16 cm⁻¹, 2952.75 cm⁻¹, and 3455.74
cm⁻¹ in the nanoparticles, respectively.
The results of the study indicate that the shifts in the peaks representing the amino group and the
carboxyl groups in the FTIR spectrum of the nanoparticles provide evidence of the interaction between the
carboxyl (-COO-) group of the anionic polymer and the amino group (-NH3+) of Chitosan. This interaction
leads to the formation of an ionic complex between the two compounds in the nanoparticulate system.
X-ray diffraction (XRD) studies
The nanoparticles containing Humulin N, along with the nanoparticulate system components,
chitosan and alginate, were analyzed using X-ray diffraction (XRD) to assess any changes in the crystalline
structure of chitosan and alginate before and after nanoparticle formation. XRD analysis of the individual
components showed that chitosan exhibited a crystalline structure, while alginate appeared to be
amorphous. The crystalline nature of chitosan was evidenced by a prominent peak at 20.38° in its X-ray
diffractogram. In contrast, alginate's diffractogram displayed no distinct peaks, indicating its amorphous
nature. Figure 7 shows the X-ray diffractograms of chitosan and alginate before nanoparticle synthesis.
Fig 7. X-Ray Diffractogram of Alginate (red) and Chitosan (black) before the formation of nanoparticles
The X-ray diffraction pattern of nanoparticles created with an initial chitosan content of 0.05%.,
0.07% and 0.09%. represents the values of Figure 8. The diffractogram shows that a solitary significant
Table 3 Peak Values of FTIR spectra of Alginate, Chitosan and Nanoparticles with Humulin N
Samples
Alginate (COO-) &
Chitosan (NH3
+)
Nanoparticles with Humulin N
Functional groups
COO--
1738.31
1738.49
NH3
+
1501.72
1510.38
1654.73
1646.40
3045.94
2931.50
3079.94
2964.08
3147.95
3420.32
changes in the crystalline structure of chitosan and
alginate before and after nanoparticle formation.
XRD analysis of the individual components showed
that chitosan exhibited a crystalline structure,
while alginate appeared to be amorphous. The
crystalline nature of chitosan was evidenced by a
prominent peak at 20.38° in its X-ray diffractogram.
In contrast, alginate’s diffractogram displayed no
distinct peaks, indicating its amorphous nature.
Figure 7 shows the X-ray diffractograms of chitosan
and alginate before nanoparticle synthesis.
The X-ray diffraction pattern of nanoparticles
created with an initial chitosan content of 0.05%.,
0.07% and 0.09%. represents the values of Figure
8. The diffractogram shows that a solitary significant
peak of chitosan vanished following the creation of
the nanoparticles. All three nanoparticles have an
amorphous structure.
Thus, the decline in crystallinity of chitosan may
be caused due to interaction with alginate and other
components of the nanoparticulate system. The result
Fig 6. FTIR spectrum of Chitosan (blue), Alginate (red), and Nanoparticles with initial chitosan
concentration of 0.05% (green), 0.07% (orange), and 0.09% (violet)
Fig 7. X-Ray Diffractogram of Alginate (red) and Chitosan (black) before the formation of nanoparticles
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
obtained in the current study is in accordance with the
observations by Lin et al, 2007 where the disruption
of the crystal structure of the chitosan was observed
after chitosan combined with γ-PGA via electrostatic
interactions to form Chitosan-γ-PGA nanoparticles.
Synthesis and characterization of Insulin
loaded nanoparticles by Ionic Pregelation with
Polyelectrolyte complexation method
Scanning Electron Microscopy studies
Alginate chitosan nanoparticles were synthesized.
On slow addition of the chitosan over the pregel mixture
(formed by addition of CaCl2 over the alginate insulin
solution), the solution changed from clear to opalescent
and finally turning turbid indicating the formation of
the insulin loaded nanoparticles. This synthesis was
Fig 9. Scannniing Electron Micrographs of Insulin Loadded Nannoparticles
Volume 111 | Issue 7-9 |
peak of chitosan vanished following the creation of the nanoparticles. All three nanoparticles have an
amorphous structure.
Figure 8 X-Ray Diffractograms of Nanoparticles with initial chitosan concentration of 0.05% (Green), 0.07%
(Blue), and 0.09% (Red)
Thus, the decline in crystallinity of chitosan may be caused due to interaction with alginate and
other components of the nanoparticulate system. The result obtained in the current study is in accordance
with the observations by Lin et al, 2007 where the disruption of the crystal structure of the chitosan was
observed after chitosan combined with γ-PGA via electrostatic interactions to form Chitosan-γ-PGA
nanoparticles.
Synthesis and characterization of Inssulin loaded nanoparticles by Ionic Pregelation with
Polyelectrolytte complexation method
Scanning Electron Microscopy studies
Alginate chitosan nanoparticles were synthesized. On slow addition of the chitosan over the
pregel mixture (formed by addition of CaCl2 over the alginate insulin solution), the solution changed from
clear to opalescent and finally turning turbid indicating the formation of the insulin loaded nanoparticles.
This synthesis was carried out and the size of the nanoparticles formed was studied using scanning
electron microscopy. Isophane insulin (Humulin N®) suspension was taken as source of insulin for
synthesis. The sizes of the nanoparticles formed ranged between 326 nm – 850 nm and the nanoparticles
were not regular spheres as observed from the scanning electron micrographs. The scanning electron
micrographs of the nanoparticles synthesized is represented in Figure 9. Particles below 1000 nm are
desirable as they are better absorbed in the intestinal tract.
carried out and the size of the nanoparticles formed
was studied using scanning electron microscopy.
Isophane insulin (Humulin N®) suspension was taken
as source of insulin for synthesis. The sizes of the
nanoparticles formed ranged between 326 nm – 850
nm and the nanoparticles were not regular spheres as
observed from the scanning electron micrographs. The
scanning electron micrographs of the nanoparticles
synthesized is represented in Figure 9. Particles below
1000 nm are desirable as they are better absorbed in
the intestinal tract.
Fourier Transform Infrared Spectroscopy (FTIR)
studies
The nanoparticles synthesized with Humulin N
as insulin sources were subjected to FTIR studies.
Figure 10 shows a combined representation of the
FTIR spectra of alginate, Chitosan and nanoparticles
synthesized with Humulin N. The peak values were
noted and investigated for the shift in the peak values
of amino group and the carboxyl group.
The peak values are displayed in the table 1. The
peak values of alginate and chitosan were subjected
to comparison with the peak values of nanoparticles
with Humulin N individually in order to ascertain
the interaction between the components of the
nanoparticulate systems.
The following observations were made from the
FTIR spectra of Humulin N as insulin source. There is a
presence of shifts in the peak values of amino groups
from 1501.72 cm-1, 1654.73 cm-1, 3045.94 cm-1 ,
3079.94 cm-1 and 3147.95 cm-1 in chitosan to 1510.38
Figure 8 X-Ray Diffractograms of Nanoparticles with initial chitosan concentration of 0.05%
(Green), 0.07% (Blue), and 0.09% (Red)
Fig 9. Scanning Electron Micrographs of
Insulin Loaded Nanoparticles
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Volume 111 | Issue 7-9 |
p
p
g
,
p
y
with Humulin N. The peak values were noted and investigated for the shift in the peak values of amino
group and the carboxyl group.
The peak values are displayed in the table 1. The peak values of alginate and chitosan were
subjected to comparison with the peak values of nanoparticles with Humulin N individually in order to
ascertain the interaction between the components of the nanoparticulate systems.
Fig 10. FTIR spectra of Alginate (red), Chitosan (blue), Nanoparticles with Humulin N (green)
The following observations were made from the FTIR spectra of Humulin N as insulin source. There
is a presence of shifts in the peak values of amino groups from 1501.72 cm-1, 1654.73 cm-1, 3045.94 cm-
1 , 3079.94 cm-1 and 3147.95 cm-1 in chitosan to 1510.38 cm-1, 1646.40 cm-1, 2931.30.66 cm-1,
2964.08 cm-1, 3420.32 cm-1 in nanoparticles with Humulin N as insulin source. The shift was also
observed in the carboxyl group peaks from 1738.31 cm-1 in alginate to 1738.49 cm-1 in the nanoparticles
with Humulin N.
From the results of the present study, it is evident that the shifts in the peaks representing the
amino group and the carboxyl groups in the FTIR spectrum of the nanoparticles confirms the interaction
between the the carboxyl (-COO-) group of the anionic polymer and the amino group (-NH3+) of chitosan to
form an ionic complex between the two compounds in the nanoparticulate system in the present study.
X-Ray Diffraction studies
Fig 11. X-Ray Diffractogram of Chitosan (red) , alginate (blue)and Nanoparticles with Humulin N (green)
The observations from the X-Ray Diffractogram of nanoparticles with H Humulin N shows the
decrease in the crystallinity of the Chitosan which is evident from the absence of a single clear peak at
20.38° in the X-Ray diffractogram with the intensity equal to that of the Chitosan before the formation of
the nanoparticles. The X-Ray diffractogram of chitosan, alginate and the nanoparticles with Humulin N is
shown in the figure 11.
Association Efficiency
The nanoparticles were analyzed for the amount of insulin associated with it after the synthesis. This study
was carried out by investigating the supernatant obtained after the centrifugation of the reaction mixture to
HPLC for the presence of insulin. Standard calibration curves for both types of insulin used in the study
were constructed by running known amounts of insulin (Humulin N) in the HPLC. The Standard
Chromatogram of the Humulin N are as shown in the figure 12. The peak at approximately 11 minutes
indicates presence and amount of insulin in the sample.
cm-1, 1646.40 cm-1, 2931.30.66 cm-1, 2964.08 cm-
1, 3420.32 cm-1 in nanoparticles with Humulin N as
insulin source. The shift was also observed in the
carboxyl group peaks from 1738.31 cm-1 in alginate
to 1738.49 cm-1 in the nanoparticles with Humulin N.
From the results of the present study, it is evident
that the shifts in the peaks representing the amino
group and the carboxyl groups in the FTIR spectrum
of the nanoparticles confirms the interaction between
the the carboxyl (-COO-) group of the anionic polymer
and the amino group (-NH3
+) of chitosan to form an
ionic complex between the two compounds in the
nanoparticulate system in the present study.
X-Ray Diffraction studies
The observations from the X-Ray Diffractogram of
nanoparticles with H Humulin N shows the decrease in
the crystallinity of the Chitosan which is evident from
the absence of a single clear peak at 20.38° in the
X-Ray diffractogram with the intensity equal to that of
the Chitosan before the formation of the nanoparticles.
The X-Ray diffractogram of chitosan, alginate and the
nanoparticles with Humulin N is shown in the figure
11.
Association Efficiency
The nanoparticles were analyzed for the amount
of insulin associated with it after the synthesis. This
study was carried out by investigating the supernatant
obtained after the centrifugation of the reaction
mixture to HPLC for the presence of insulin. Standard
calibration curves for both types of insulin used in the
study were constructed by running known amounts
of insulin (Humulin N) in the HPLC. The Standard
Chromatogram of the Humulin N are as shown in
the figure 12. The peak at approximately 11 minutes
indicates presence and amount of insulin in the
sample.
Fig 10. FTIR spectra of Alginate (red), Chitosan (blue), Nanoparticles with Humulin N (green)
Fig 11. X-Ray Diffractogram of Chitosan (red) , alginate (blue)and Nanoparticles with Humulin N
(green)
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Volume 111 | Issue 7-9 |
Fig 11. X-Ray Diffractogram of Chitosan (red) , alginate (blue)and Nanoparticles with Humulin N (green)
The observations from the X-Ray Diffractogram of nanoparticles with H Humulin N shows the
decrease in the crystallinity of the Chitosan which is evident from the absence of a single clear peak at
20.38° in the X-Ray diffractogram with the intensity equal to that of the Chitosan before the formation of
the nanoparticles. The X-Ray diffractogram of chitosan, alginate and the nanoparticles with Humulin N is
shown in the figure 11.
Association Efficiency
The nanoparticles were analyzed for the amount of insulin associated with it after the synthesis. This study
was carried out by investigating the supernatant obtained after the centrifugation of the reaction mixture to
HPLC for the presence of insulin. Standard calibration curves for both types of insulin used in the study
were constructed by running known amounts of insulin (Humulin N) in the HPLC. The Standard
Chromatogram of the Humulin N are as shown in the figure 12. The peak at approximately 11 minutes
indicates presence and amount of insulin in the sample.
Fig 12. Chromatogram of standard Humulin N
In the above chromatograms, a peak at approximately 6 minutes is observed. This presence of this peak
may not be considered as there is a similar peak observed when deionised water was run in the same
column with the same linear gradient program as followed for analysis of standards and the sample .Figure
13 displays the standard calibration curve of Humulin n. The efficiency of the insulin's association with the
nanoparticles was determined to be 55.3±3.066 (%)
Fig. 13 Staandard Calibration curve of Humulin N in HPLC.
Invitro Insulin Release Studies
In the above chromatograms, a peak at
approximately 6 minutes is observed. This presence
of this peak may not be considered as there is a
similar peak observed when deionised water was run
in the same column with the same linear gradient
program as followed for analysis of standards and the
sample .Figure 13 displays the standard calibration
curve of Humulin n. The efficiency of the insulin’s
association with the nanoparticles was determined to
be 55.3±3.066 (%)
Invitro Insulin Release Studies
The amount of insulin released in the simulated
gastric fluid and simulated intestinal fluid is as shown
in the Figure 14. It is observed that 34.7% of the
associated insulin was released in the simulated
Gastric fluid and that 77.27% of the associated insulin
was released in the simulated intestinal fluid.
In the first two hours of the study, a burst release
pattern was observed, where a significant amount of
insulin was rapidly released from the nanoparticles into
both simulated gastric and intestinal fluids. This initial
release likely stems from weak interactions between
insulin and the nanoparticle surfaces, as the alginate
core may lack sufficient strength to fully retain the
insulin. Approximately 30% of the insulin maintained
a stable interaction with the nanoparticles even after
2 hours in the release media. Comparatively, the type
of insulin used for encapsulation did not significantly
affect the release pattern, aligning with findings by
Sarmento et al., 2006b. The standard chromatogram
of the in vitro insulin release study is shown in Figure
15
A distinct peak at approximately 11 minutes
suggests the presence of insulin without detectable
Fig 12. Chromatogram of standard Humulin N
Fig. 13 Standard Calibration curve of Humulin N in HPLC.
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
In the first two hours of the study, a burst release pattern was observed, where a significant amount of
insulin was rapidly released from the nanoparticles into both simulated gastric and intestinal fluids. This
initial release likely stems from weak interactions between insulin and the nanoparticle surfaces, as the
alginate core may lack sufficient strength to fully retain the insulin. Approximately 30% of the insulin
maintained a stable interaction with the nanoparticles even after 2 hours in the release media.
Comparatively, the type of insulin used for encapsulation did not significantly affect the release pattern,
aligning with findings by Sarmento et al., 2006b. The standard chromatogram of the in vitro insulin release
study is shown in Figure 15
Figure 15 Chromatogram of Humulin N in simulated intestinal fluid
A distinct peak at approximately 11 minutes suggests the presence of insulin without detectable hydrolysis
hydrolysis degradation products. This aligns with
findings by Sarmento et al. (2006b), indicating that
nanoparticulate carriers can preserve the primary
structure of insulin during encapsulation. Therefore,
changing the type of insulin as the core material has
minimal impact on the coating material’s ability to
retain insulin’s primary structure.
Nanoparticle incorporated into milk
The insulin loaded nanoparticles which were
investigated for their release characteristics were
synthesized again and were lyophilized. The lyophilized
nanoparticles were then added to 4.5% fat standard
milk and mixed thoroughly for few seconds using a
blender. There were no settling or sedimentation of the
nanoparticles in the milk. The milk containing Insulin
loaded nanoparticles are as shown in the figure 16.
In order to study if there are any differences in
the physical properties of the control (milk without
nanoparticles) and the product (milk containing the
insulin loaded nanoparticles), a sensory analysis of
appearance (whiteness), aroma and the consistency
was conducted on a 9 point hedonic scale from 20
panel members . The results of the sensory analyses
of appearance, aroma and consistency are as
represented in figure 17.
The nutritional profiles of the milk without and
with the nanoparticles are as shown in Figure18
and Figure 19 respectively. From the results of the
nutritional analysis studies, it was observed that
there is no significant difference in the total fat, ash
and moisture content between the control and the
product. A difference of 0.2g in protein per 100 mL of
milk was observed. The product showed 0.2 g increase
in protein compared to the control.
This may be due to the release of insulin which are
held on the surfaces of the coating material by weak
interactions. Further investigations are needed to be
made in the development of a method for estimating
the presence and the amount of insulin present in the
milk samples.
Volume 111 | Issue 7-9 |
Invitro Insulin Release Studies
The amount of insulin released in the simulated gastric fluid and simulated intestinal fluid is as shown in
the Figure 14. It is observed that 34.7% of the associated insulin was released in the simulated Gastric
fluid and that 77.27% of the associated insulin was released in the simulated intestinal fluid.
Fig 14. Insulin Release vs Time Profile in Simulated Gastric fluid (Blue) and Simulated Intestinal fluid (Red)
Fig 14. Insulin Release vs Time Profile in Simulated Gastric fluid (Blue) and Simulated Intestinal
fluid (Red)
Figure 15 Chromatogram of Humulin N in simulated intestinal fluid
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Figure 16 Standard milk (left) and milk containing insulin loaded nanoparticles (right)
In order to study if there are any differences in the physical properties of the control (milk without
nanoparticles) and the product (milk containing the insulin loaded nanoparticles), a sensory analysis of
appearance (whiteness), aroma and the consistency was conducted on a 9 point hedonic scale from 20
panel members . The results of the sensory analyses of appearance, aroma and consistency are as
represented in figure 17.
Figure 17 Sensory Analysis of Standard milk and Product (Milk Containing Insulin loaded nanoparticle
The nutritional profiles of the milk without and with the nanoparticles are as shown in Figure18 and Figure
19 respectively. From the results of the nutritional analysis studies, it was observed that there is no
significant difference in the total fat, ash and moisture content between the control and the product. A
difference of 0.2g in protein per 100 mL of milk was observed. The product showed 0.2 g increase in
protein compared to the control.
Figure 18 Nutritional Profile of Control (standard milk)
Volume 111 | Issue 7-9 |
Figure 16 Staandard milk (left) and milk containing insulin loaded nanoparticles (right)
In order to study if there are any differences in the physical properties of the control (milk without
nanoparticles) and the product (milk containing the insulin loaded nanoparticles), a sensory analysis of
appearance (whiteness), aroma and the consistency was conducted on a 9 point hedonic scale from 20
panel members . The results of the sensory analyses of appearance, aroma and consistency are as
represented in figure 17.
Figure 17 Sensory Analysis of Standard milk and Product (Milk Containing Insulin loaded nanoparrticle
The nutritional profiles of the milk without and with the nanoparticles are as shown in Figure18 and Figure
19 respectively. From the results of the nutritional analysis studies, it was observed that there is no
significant difference in the total fat, ash and moisture content between the control and the product. A
difference of 0.2g in protein per 100 mL of milk was observed. The product showed 0.2 g increase in
protein compared to the control.
Figure 18 Nutritional Profile of Control (standard milk)
Volume 111 | Issue 7-9 |
The insulin loaded nanoparticles which were investigated for their release characteristics were
synthesized again and were lyophilized. The lyophilized nanoparticles were then added to 4.5% fat
standard milk and mixed thoroughly for few seconds using a blender. There were no settling or
sedimentation of the nanoparticles in the milk. The milk containing Insulin loaded nanoparticles are as
shown in the figure 16.
CONCLUSION
The study concludes that nanoparticles synthesized
with an initial concentration of 0.05% formed
nanofiber-like structures, while those with 0.07%
and 0.09% concentrations showed agglomeration in
scanning electron micrographs. FTIR analysis revealed
well-established interactions between the components
across all three nanoparticle variants. Additionally,
the crystalline nature of the components diminished
or was completely disrupted upon nanoparticle
formation. Due to the relatively low insulin association
efficiency within the nanoparticles synthesized through
this method, further studies, such as in vitro release
Figure 16 Standard milk (left) and milk containing insulin loaded nanoparticles (right)
Figure 17. Sensory Analysis of Standard milk and Product (Milk Containing Insulin loaded
nanoparticle
Figure 18 Nutritional Profile of Control (standard milk)
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Volume 111 | Issue 7-9 |
Figure 19 Nutritional Profile of the Product (Milk containing Insulin loaded nanoparticles)
This may be due to the release of insulin which are held on the surfaces of the coating material by weak
interactions. Further investigations are needed to be made in the development of a method for estimating
the presence and the amount of insulin present in the milk samples.
CONCLUSION
The study concludes that nanoparticles synthesized with an initial concentration of 0.05% formed
nanofiber-like structures, while those with 0.07% and 0.09% concentrations showed agglomeration in
scanning electron micrographs. FTIR analysis revealed well-established interactions between the
components across all three nanoparticle variants. Additionally, the crystalline nature of the components
diminished or was completely disrupted upon nanoparticle formation. Due to the relatively low insulin
association efficiency within the nanoparticles synthesized through this method, further studies, such as in
vitro release testing, were not pursued. The Isophane insulin-loaded nanoparticles were subsequently
mixed with milk to produce the final product, which underwent nutritional analysis. This analysis indicated
an increase in protein content compared to the control sample. Sensory evaluations of color, aroma, and
consistency were conducted on both the product and the control, with results showing no significant
differences, suggesting that the inclusion of insulin-loaded nanoparticles did not impact these attributes.
Based on this study, it is concluded that the product containing insulin-loaded nanoparticles demonstrates
effective insulin release characteristics and exhibits no notable differences in nutritional or sensory
attributes, such as aroma, appearance, and consistency, when compared to standard milk.
REFERENCES
testing, were not pursued. The Isophane insulin-loaded
nanoparticles were subsequently mixed with milk to
produce the final product, which underwent nutritional
analysis. This analysis indicated an increase in protein
content compared to the control sample. Sensory
evaluations of color, aroma, and consistency were
conducted on both the product and the control, with
results showing no significant differences, suggesting
that the inclusion of insulin-loaded nanoparticles did
not impact these attributes. Based on this study, it is
concluded that the product containing insulin-loaded
nanoparticles demonstrates effective insulin release
characteristics and exhibits no notable differences
in nutritional or sensory attributes, such as aroma,
appearance, and consistency, when compared to
standard milk.
REFERENCES
ABD EL SALAM, M. H., S. El Shibiny. 2012. Formation and
potential uses of milk proteins as nano delivery
vehicles for nutraceuticals: a review. International
journal of dairy technology, 65(1), 13-21. https://
doi.org/10.1111/j.1471-0307.2011.00737.x
Elsayed, A., M. Al-Remawi, N. Qinna, A. Farouk, K.A.
Al-Sou’od, and A.A. Badwan. 2011. Chitosan–
sodium lauryl sulfate nanoparticles as a carrier
system for the in vivo delivery of oral insulin.
Aaps Pharmscitech, 12, 958-964. https://doi.
org/10.1208/s12249-011-9647-5
Finotelli, P. V., D. Da Silva, M. Sola-Penna, A.M. Rossi,
M. Farina, L.R. Andrade, ... andM.H. Rocha-
Leão. 2010. Microcapsules of alginate/chitosan
containing magnetic nanoparticles for controlled
release of insulin. Colloids and Surfaces B:
Biointerfaces,
81(1),
206-211.
https://doi.
org/10.1016/j.colsurfb.2010.07.008
Hussain, N., V. Jaitley, and A.T. Florence. 2001. Recent
advances in the understanding of uptake of
microparticulates across the gastrointestinal
lymphatics. Advanced drug delivery reviews,
50(1-2), 107-142. https://doi.org/10.1016/S0169-
409X(01)00152-1
Li, P., Y.N. Dai, J.P. Zhang, A.Q. Wang, and Q.Wei. 2008.
Chitosan-alginate nanoparticles as a novel drug
delivery system for nifedipine. International
journal of biomedical science: IJBS, 4(3), 221.
PMID: 23675094
Lin, Y. H., F.L. Mi, C.T. Chen, W.C. Chang, S.F. Peng,
H.F. Liang, and H.W. Sung. 2007. Preparation
and
characterization
of
nanoparticles
shelled with chitosan for oral insulin delivery.
Biomacromolecules, 8(1), 146-152. https://pubs.
acs.org/doi/abs/10.1021/bm0607776
Makhlof, A., Y.Tozuka, and H. Takeuchi. 2011. Design
and evaluation of novel pH-sensitive chitosan
nanoparticles for oral insulin delivery. European
journal of pharmaceutical sciences, 42(5), 445-
451. https://doi.org/10.1016/j.ejps.2010.12.007
Mobasseri, M., Shirmohammadi, M., Amiri, T., Vahed,
N., Hosseini Fard, H., & Ghojazadeh, M. 2020.
Prevalence and incidence of type 1 diabetes
in the world: a systematic review and meta-
analysis. Health promotion perspectives, 10(2),
98–115. https://doi.org/10.34172/hpp.2020.18
Panyam, J., V. Labhasetwar. 2003. Biodegradable
nanoparticles for drug and gene delivery to cells
and tissue. Advanced drug delivery reviews,
55(3), 329-347. https://doi.org/10.1016/S0169-
409X(02)00228-4
Figure 19 Nutritional Profile of the Product (Milk containing Insulin loaded nanoparticles)
MadrasAgric.J.,2024; https://doi.org/10.29321/MAJ.10.500021
111|7-9|
Sarmento, B., A. Ribeiro, F. Veiga, P. Sampaio, R.
Neufeld, and D. Ferreira. 2007. Alginate/
chitosan nanoparticles are effective for oral
insulin delivery. Pharmaceutical research, 24,
2198-2206. https://doi.org/10.1007/s11095-007-
9367-4
Sarmento, B., A.J. Ribeiro, F. Veiga, D.C. Ferreira, and
R. J. Neufeld. 2007. Insulin-loaded nanoparticles
are prepared by alginate ionotropic pre-
gelation followed by chitosan polyelectrolyte
complexation. Journal of nanoscience and
nanotechnology, 7(8), 2833-2841. https://doi.
org/10.1166/jnn.2007.609
Sarmento, B., D. Ferreira, F. Veiga, and A. Ribeiro.
2006.
Characterization
of
insulin-loaded
alginate nanoparticles produced by ionotropic
pre-gelation through DSC and FTIR studies.
Carbohydrate polymers, 66(1), 1-7. https://doi.
org/10.1016/j.carbpol.2006.02.008